REVATIO Side Effects

6910349-6 | Abdominal Pain, Cardiopulmonary Failure
on Jul 26, 2010 Female patient from GERMANY , 85 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), cardiopulmonary failure. Revatio dosage: Unk.

6888189-6 | Abasia, Convulsion, Dyspnoea, Fatigue, Haemoglobin Decreased, Hearing Impaired, Heart Rate Irregular, Overdose
Patient was taking Revatio (View Usage). Patient had the following side effects: abasia, convulsion, dyspnoea, fatigue, haemoglobin decreased, hearing impaired, heart rate irregular, overdose on Jul 19, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 197.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), convulsion, cardiac disorder and. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with DILANTIN 125 (Unk) (View Dilantin-125 Review and Dilantin-125 Label ), COREG (6.25 Mg, 2x/day) (View Coreg Review and Coreg Label ), KEPPRA (Unk) (View Keppra Review and Keppra Label ), BUMETANIDE (Unk) (View Bumetanide Review and Bumetanide Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), SPIRONOLACTONE (Unk) (View Spironolactone Review and Spironolactone Label ), SYNTHROID (0.75 (units Unk)) (View Synthroid Review and Synthroid Label ), WARFARIN (03 Mg (written As Is)) (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6878310-8 | Back Pain, Hypoacusis, Vision Blurred
Adverse event was reported on Jul 19, 2010 by a Female patient taking Revatio (View Usage) (Dosage: Unk) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), pulmonary arterial hypertension, chronic obstructive pulmonary disease and. Location: FRANCE , 81 years of age, After Revatio was administered, patient had the following side effects: back pain (What is back pain?), hypoacusis, vision blurred. During the same period patient was treated with AMBRISENTAN (Unk) (View Ambrisentan Review and Ambrisentan Label ), FLIXOTIDE DISKUS (Unk) (View Flixotide Diskus Review and Flixotide Diskus Label ), VENTOLIN (Unk) (View Ventolin Review and Ventolin Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), PREVISCAN (Unk) (View Previscan Review and Previscan Label ), ACETAMINOPHEN (Unk) (View Acetaminophen Review and Acetaminophen Label ), PANTOPRAZOLE SODIUM (Unk) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ).

6878295-4 | Blood Bilirubin Increased, Hepatic Function Abnormal
on Jul 16, 2010 Male patient from NETHERLANDS , 15 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, hepatic function abnormal. Revatio dosage: 20 Mg, 4x/day. During the same period patient was treated with DOMPERIDONE (9 Ml, As Needed) (View Domperidone Review and Domperidone Label ).


6875865-4 | Cardiac Failure Congestive, Pleural Effusion, Pulmonary Arterial Hypertension, Renal Failure Chronic, Type 2 Diabetes Mellitus
on Jul 14, 2010 Female patient from AUSTRALIA , 66 years of age, was diagnosed with pulmonary arterial hypertension, pulmonary hypertension (What is pulmonary hypertension?), coronary artery disease (What is coronary artery disease?) and was treated with Revatio (View Usage). Patient had the following side effects: cardiac failure congestive, pleural effusion, pulmonary arterial hypertension, renal failure chronic, type 2 diabetes mellitus. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with BOSENTAN (125 Mg, 2x/day) (View Bosentan Review and Bosentan Label ), HYDRALAZINE (25 Mg, 2x/day) (View Hydralazine Review and Hydralazine Label ), LASIX (40 Mg, 1x/day) (View Lasix Review and Lasix Label ), PLAVIX (75 Mg, 1x/day) (View Plavix Review and Plavix Label ).

6872124-0 | Paraesthesia
Patient was taking Revatio (View Usage). After Revatio was administered, patient had the following side effects: paraesthesia on Jul 12, 2010 from FRANCE Additional patient health information: Female patient , child 11 years of age, weighting 79.37 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), pulmonary arterial hypertension and. Revatio dosage: Dose Increased. During the same period patient was treated with REMODULIN (39 Ng/kg/min) (View Remodulin Review and Remodulin Label ), TRACLEER (62.5 Mg, 1x/day) (View Tracleer Review and Tracleer Label ), PREVISCAN (Around 18 Mg, 1x/day) (View Previscan Review and Previscan Label ), FLOLAN (View Flolan Review and Flolan Label ).

6872121-5 | Emphysema, Lung Disorder
Adverse event was reported on Jul 16, 2010 by a Female patient taking Revatio (View Usage) (Dosage: 20 Mg, 3x/day) was diagnosed with lung disorder, pulmonary hypertension (What is pulmonary hypertension?), depression (What is depression?), hip fracture, pain in extremity, arthritis (What is arthritis?) and. Location: UNITED STATES , weighting 115.1 lb, Patient experienced the following unwanted or unexpected effects: emphysema, lung disorder. During the same period patient was treated with ZOLOFT (Unk) (View Zoloft Review and Zoloft Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (5 Mg, As Needed) (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ).

6872069-6 | Oxygen Saturation Decreased, Periodontitis, Pulmonary Arterial Pressure Increased, Pulpitis Dental, Tooth Loss
on Jul 13, 2010 Female patient from GERMANY , 52 years of age, weighting 136.7 lb, was diagnosed with pulmonary arterial hypertension, thrombosis prophylaxis and was treated with Revatio (View Usage). Patient had the following side effects: oxygen saturation decreased, periodontitis, pulmonary arterial pressure increased, pulpitis dental, tooth loss. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with MARCUMAR (2.5 - 3.0 Mg Per Day) (View Marcumar Review and Marcumar Label ), TORASEMIDE (5 Mg, Unk) (View Torasemide Review and Torasemide Label ).

6871975-6 | Dyspnoea
on Jul 13, 2010 Male patient from UNITED STATES , weighting 130.0 lb, was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: dyspnoea. Revatio dosage: Unk Mg, Unk. Patient was hospitalized.

6870067-X | Altered State Of Consciousness, Blood Creatinine Increased, Renal Failure, Shoulder Operation
Patient was taking Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, blood creatinine increased, renal failure, shoulder operation on Jul 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 242.9 lb, was diagnosed with pulmonary arterial hypertension, pulmonary hypertension (What is pulmonary hypertension?), cardiac failure and. Revatio dosage: 40 Mg, 3x/day. During the same period patient was treated with BUMEX (4 Mg/3 Mg, 2x/day) (View Bumex Review and Bumex Label ), TRACLEER (125 Mg, 2x/day) (View Tracleer Review and Tracleer Label ). Patient was hospitalized.

6861129-1 | Cough, Dyspnoea, Vocal Cord Thickening
Adverse event was reported on Jul 08, 2010 by a Female patient taking Revatio (View Usage) (Dosage: 20 Mg, 3x/day) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), thyroid disorder and. Location: UNITED STATES , weighting 229.3 lb, Patient had the following side effects: cough, dyspnoea, vocal cord thickening. During the same period patient was treated with SYNTHROID (125 Mg, 1x/day) (View Synthroid Review and Synthroid Label ), ZIAC (25 Mg, 1x/day) (View Ziac Review and Ziac Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6857352-2 | Cerebrovascular Accident, Pulmonary Hypertension
on Jul 07, 2010 Female patient from UNITED STATES , weighting 252.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: cerebrovascular accident, pulmonary hypertension (What is pulmonary hypertension?). Revatio dosage: 40 Mg, 3x/day. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), WARFARIN (View Warfarin Review and Warfarin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), OXYGEN (View Oxygen Review and Oxygen Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), VALSARTAN (View Valsartan Review and Valsartan Label ).

6848280-7 | Pulmonary Fibrosis
on Jul 06, 2010 Female patient from UNITED STATES , weighting 180.0 lb, was diagnosed with systemic sclerosis, pulmonary fibrosis (What is pulmonary fibrosis?) and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary fibrosis (What is pulmonary fibrosis?). Revatio dosage: 20 Mg, 3x/day. Patient was hospitalized.

6831318-0 | Abdominal Pain, Cardiac Pacemaker Insertion, Gastrointestinal Haemorrhage
Patient was taking Revatio (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), cardiac pacemaker insertion, gastrointestinal haemorrhage on Jun 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 205.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), atrial fibrillation (What is atrial fibrillation?) and. Revatio dosage: Unk. During the same period patient was treated with WARFARIN (Unk) (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6826691-3 | Angioedema, Flushing, Headache, Throat Tightness
Adverse event was reported on Jun 29, 2010 by a Female patient taking Revatio (View Usage) (Dosage: 1 Df, Single) was diagnosed with raynaud's phenomenon and. Location: FRANCE , 26 years of age, weighting 154.3 lb, After Revatio was administered, patient had the following side effects: angioedema, flushing, headache (What is headache?), throat tightness.

6820599-5 | Monoplegia
on Jun 28, 2010 Female patient from UNITED STATES , weighting 99.98 lb, was diagnosed with emphysema, dyspnoea and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: monoplegia. Revatio dosage: 20 Mg, 2x/day. During the same period patient was treated with TRACLEER (Unk) (View Tracleer Review and Tracleer Label ), SPIRIVA (Unk) (View Spiriva Review and Spiriva Label ), ADVAIR DISKUS 100/50 (Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (Unk) (View Albuterol Review and Albuterol Label ).

6820197-3 | Arrhythmia, Hypertension
on Jun 25, 2010 Female patient from UNITED STATES , weighting 125.7 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), renal transplant and was treated with Revatio (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), hypertension. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with PROGRAF (Unk) (View Prograf Review and Prograf Label ). Patient was hospitalized.

6819420-0 | Renal Failure, Shoulder Operation
Patient was taking Revatio (View Usage). After Revatio was administered, patient had the following side effects: renal failure, shoulder operation on Jun 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 242.5 lb, was diagnosed with pulmonary arterial hypertension and. Revatio dosage: 40 Mg, 3x/day. Patient was hospitalized.

6819384-X | Cardiac Failure Congestive, Headache
Adverse event was reported on Jun 25, 2010 by a Female patient taking Revatio (View Usage) (Dosage: 20 Mg, 2x/day) was diagnosed with pulmonary arterial hypertension and. Location: JAPAN , 61 years of age, weighting 91.49 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, headache (What is headache?). During the same period patient was treated with DIGOSIN (Unk) (View Digosin Review and Digosin Label ), WARFARIN POTASSIUM (Unk) (View Warfarin Potassium Review and Warfarin Potassium Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), FUROSEMID (Unk) (View Furosemid Review and Furosemid Label ), ALDACTAZIDE A (Unk) (View Aldactazide-a Review and Aldactazide-a Label ), BERAPROST SODIUM (Unk) (View Beraprost Sodium Review and Beraprost Sodium Label ), PARIET (Unk) (View Pariet Review and Pariet Label ), TRACLEER (Unk) (View Tracleer Review and Tracleer Label ).

6813552-9 | Anaemia, Blood Creatine Phosphokinase Increased, Cardiac Failure Acute, Dyspnoea, Dysuria, Fluid Overload, Hyperammonaemia, Hypercalcaemia
on Jun 23, 2010 Female patient from UNITED STATES , weighting 155.0 lb, was diagnosed with pulmonary arterial hypertension and was treated with Revatio (View Usage). Patient had the following side effects: anaemia, blood creatine phosphokinase increased, cardiac failure acute, dyspnoea, dysuria, fluid overload, hyperammonaemia, hypercalcaemia. Revatio dosage: 40 Mg, 3x/day. Patient was hospitalized.

6812621-7 | Deafness Bilateral, Fall, Hypotension
on Jun 23, 2010 Female patient from FRANCE , 72 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: deafness bilateral, fall (What is fall?), hypotension. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with AMLOR (Unk) (View Amlor Review and Amlor Label ), LASIX (80 Mg, 2x/day) (View Lasix Review and Lasix Label ), AMITRIPTYLINE HCL (Unk) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ), CORTANCYL (Unk) (View Cortancyl Review and Cortancyl Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), FERROUS SULFATE/FOLIC ACID (Unk) (View Ferrous Sulfate/folic Acid Review and Ferrous Sulfate/folic Acid Label ), CACIT D3 (Unk) (View Cacit D3 Review and Cacit D3 Label ). Patient was hospitalized.

6809707-X | Abdominal Pain, Vomiting
Patient was taking Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), vomiting on Jun 22, 2010 from GERMANY Additional patient health information: Female patient , 85 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Revatio dosage: Unk.

6808416-0 | Eye Disorder, Eye Irritation
Adverse event was reported on Jun 24, 2009 by a Female patient taking Revatio (View Usage) (Dosage: 20 Mg, 3x/day) was diagnosed with pulmonary arterial hypertension, blood cholesterol increased and. Location: UNITED STATES , weighting 174.2 lb, Patient had the following side effects: eye disorder, eye irritation. During the same period patient was treated with PRAVASTATIN (Unk) (View Pravastatin Review and Pravastatin Label ), WARFARIN SODIUM (Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ).

6808284-7 | Abdominal Discomfort, Nasopharyngitis, Rhinorrhoea
on Jun 22, 2009 Male patient from UNITED STATES , weighting 151.5 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: abdominal discomfort, nasopharyngitis, rhinorrhoea. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PRAVACHOL (Unk) (View Pravachol Review and Pravachol Label ), MAG OX (Unk) (View Mag-ox Review and Mag-ox Label ), BENICAR (Unk) (View Benicar Review and Benicar Label ).

6808136-2 | Dyspnoea, Hepatic Enzyme Increased, Malaise
on Apr 24, 2009 Female patient from UNITED STATES , weighting 219.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, hepatic enzyme increased, malaise. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with SPIRONOLACTONE (25 Mg, Unk) (View Spironolactone Review and Spironolactone Label ), METOPROLOL (25 Mg, Unk) (View Metoprolol Review and Metoprolol Label ), WARFARIN (5 Mg, Unk) (View Warfarin Review and Warfarin Label ), POTASSIUM (10 Mg, Unk) (View Potassium Review and Potassium Label ), LASIX (40 Mg, Unk) (View Lasix Review and Lasix Label ).

6808121-0 | Blood Glucose Increased
Patient was taking Revatio (View Usage). Patient had the following side effects: blood glucose increased on Jun 16, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 134.9 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with BUMEX (Unk) (View Bumex Review and Bumex Label ), AMARYL (Unk) (View Amaryl Review and Amaryl Label ), COREG (Unk) (View Coreg Review and Coreg Label ), SODIUM BICARBONATE (Unk) (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), NORTRIPTYLINE (Unk) (View Nortriptyline Review and Nortriptyline Label ), CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label ), MULTI VITAMINS (Unk) (View Multi-vitamins Review and Multi-vitamins Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ).

6808101-5 | Dizziness, Flushing, Somnolence
Adverse event was reported on Jun 16, 2009 by a Female patient taking Revatio (View Usage) (Dosage: 20 Mg, 1x/day) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , weighting 224.9 lb, After Revatio was administered, patient had the following side effects: dizziness (What is dizziness?), flushing, somnolence. During the same period patient was treated with METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ZOCOR (Unk) (View Zocor Review and Zocor Label ), LEXAPRO (Unk) (View Lexapro Review and Lexapro Label ), ALPRAZOLAM (Unk) (View Alprazolam Review and Alprazolam Label ), POTASSIUM (Unk) (View Potassium Review and Potassium Label ), FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ).

6808099-X | Dyspnoea, Myalgia
on Mar 11, 2009 Female patient from UNITED STATES , weighting 168.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, myalgia. Revatio dosage: Unk. During the same period patient was treated with ENALAPRIL (Unk) (View Enalapril Review and Enalapril Label ), HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SYMBICORT (Unk) (View Symbicort Review and Symbicort Label ), SPIRIVA (Unk) (View Spiriva Review and Spiriva Label ), PULMICORT (Unk) (View Pulmicort Review and Pulmicort Label ).

6808086-1 | Rash
on Mar 26, 2009 Female patient from UNITED STATES , weighting 185.0 lb, was diagnosed with pulmonary arterial hypertension and was treated with Revatio (View Usage). Patient had the following side effects: rash (What is rash?). Revatio dosage: Unk. During the same period patient was treated with TRACLEER (Unk) (View Tracleer Review and Tracleer Label ), CARDIZEM (Unk) (View Cardizem Review and Cardizem Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), FERROUS SULFATE (Unk) (View Ferrous Sulfate Review and Ferrous Sulfate Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), WARFARIN (Unk) (View Warfarin Review and Warfarin Label ), OXYGEN (Unk) (View Oxygen Review and Oxygen Label ).

6807912-X | Abdominal Discomfort, Dizziness, Insomnia
Patient was taking Revatio (View Usage). After Revatio was administered, patient had the following side effects: abdominal discomfort, dizziness (What is dizziness?), insomnia on Mar 25, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 179.9 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with OXYGEN (Unk) (View Oxygen Review and Oxygen Label ), LASIX (40 Mg, 2x/day) (View Lasix Review and Lasix Label ), CUMADIN (Unk) (View Cumadin Review and Cumadin Label ), TAMSULOSIN HYDROCHLORIDE (Unk) (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ).

6807901-5 | Headache, Hypoaesthesia, Menorrhagia
Adverse event was reported on Mar 18, 2009 by a Female patient taking Revatio (View Usage) (Dosage: 20 Mg, 3x/day) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , weighting 173.9 lb, Patient experienced the following unwanted or unexpected effects: headache (What is headache?), hypoaesthesia, menorrhagia. During the same period patient was treated with ALLEGRA (Unk) (View Allegra Review and Allegra Label ), LANOXIN (0.125 Mg, 1x/day) (View Lanoxin Review and Lanoxin Label ), FUROSEMIDE (10mg In The Morning And 10mg At 1pm) (View Furosemide Review and Furosemide Label ), POTASSIUM (2 Tablets At Night) (View Potassium Review and Potassium Label ), VITAMINS (Unk) (View Vitamins Review and Vitamins Label ), VITAMIN C (Unk) (View Vitamin C Review and Vitamin C Label ).

6807881-2 | Dizziness, Fatigue, Gastric Disorder, Headache, Hyperhidrosis, Influenza Like Illness, Malaise
on Mar 27, 2009 Male patient from UNITED STATES , weighting 220.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient had the following side effects: dizziness (What is dizziness?), fatigue, gastric disorder, headache (What is headache?), hyperhidrosis, influenza like illness, malaise. Revatio dosage: 20 Mg, Unk. During the same period patient was treated with COUMADIN (Unk) (View Coumadin Review and Coumadin Label ).

6807866-6 | Asthenia, Dyspnoea
on Jan 27, 2009 Male patient from UNITED STATES , weighting 255.7 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), pulmonary oedema and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: asthenia, dyspnoea. Revatio dosage: . During the same period patient was treated with OXYGEN (Unk) (View Oxygen Review and Oxygen Label ), SPIRIVA (Unk) (View Spiriva Review and Spiriva Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), VITAMINS NOS (Unk) (View Vitamins Nos Review and Vitamins Nos Label ).

6807717-X | Deafness
Patient was taking Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: deafness on Nov 07, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 160.3 lb, was diagnosed with pulmonary arterial hypertension and. Revatio dosage: . During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), WARFARIN (View Warfarin Review and Warfarin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6807690-4 | Deafness
Adverse event was reported on Nov 03, 2008 by a Male patient taking Revatio (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 160.3 lb, Patient had the following side effects: deafness. During the same period patient was treated with BOSENTAN (View Bosentan Review and Bosentan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), WARFARIN (View Warfarin Review and Warfarin Label ).

6807419-X | Menorrhagia
on Sep 19, 2008 Female patient from UNITED STATES , weighting 164.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: menorrhagia. Revatio dosage: . During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6807416-4 | Blood Glucose Increased, Headache, Oedema Peripheral, Respiratory Depth Increased, Weight Increased, Wheezing
on May 15, 2009 Female patient from UNITED STATES , weighting 195.1 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), thrombosis and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, headache (What is headache?), oedema peripheral, respiratory depth increased, weight increased, wheezing. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), COUMADIN (View Coumadin Review and Coumadin Label ), COZAAR (View Cozaar Review and Cozaar Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), POTASSIUM (View Potassium Review and Potassium Label ), ZOLOFT (View Zoloft Review and Zoloft Label ).

6807390-0 | Arthritis, Respiratory Disorder
Patient was taking Revatio (View Usage). Patient had the following side effects: arthritis (What is arthritis?), respiratory disorder on Nov 10, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 180.8 lb, was diagnosed with pulmonary arterial hypertension and. Revatio dosage: . During the same period patient was treated with VIAGRA (View Viagra Review and Viagra Label ).

6807386-9 | Hepatic Pain
Adverse event was reported on Sep 11, 2008 by a Male patient taking Revatio (View Usage) (Dosage: ) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , weighting 185.4 lb, After Revatio was administered, patient had the following side effects: hepatic pain. During the same period patient was treated with VIAGRA (View Viagra Review and Viagra Label ), AMBRISENTAN (View Ambrisentan Review and Ambrisentan Label ), PROCATEROL HCL (View Procaterol Hcl Review and Procaterol Hcl Label ), PROTONIX (View Protonix Review and Protonix Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), BELLADENAL (View Belladenal Review and Belladenal Label ).

6807367-5 | Dyspnoea, Fatigue
on Nov 20, 2008 Female patient from UNITED STATES , weighting 139.3 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, fatigue. Revatio dosage: 5 Every 1 Days. During the same period patient was treated with ZETIA (View Zetia Review and Zetia Label ), POTASSIUM (View Potassium Review and Potassium Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), REMODULIN (View Remodulin Review and Remodulin Label ).

6807135-4 | Burning Sensation, Dyspnoea, Fatigue, Headache, Musculoskeletal Pain, Pruritus, Rash, Scab
on Aug 30, 2008 Female patient from UNITED STATES , weighting 180.4 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient had the following side effects: burning sensation, dyspnoea, fatigue, headache (What is headache?), musculoskeletal pain, pruritus, rash (What is rash?), scab (What is scab?). Revatio dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6807101-9 | Deafness
Patient was taking Revatio (View Usage). After Revatio was administered, patient had the following side effects: deafness on Jun 24, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 246.5 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Revatio dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), XANAX (View Xanax Review and Xanax Label ), ASTELIN (View Astelin Review and Astelin Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), BENADRYL (View Benadryl Review and Benadryl Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6807085-3 | Oedema Peripheral, Renal Impairment
Adverse event was reported on Aug 07, 2008 by a Female patient taking Revatio (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , weighting 240.5 lb, Patient experienced the following unwanted or unexpected effects: oedema peripheral, renal impairment. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), NORVASC (View Norvasc Review and Norvasc Label ), LASIX (View Lasix Review and Lasix Label ).

6805636-6 | Hypersensitivity, Nasal Oedema, Sneezing, Upper Airway Obstruction
on Feb 26, 2008 Male patient from UNITED STATES , weighting 190.3 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). Patient had the following side effects: hypersensitivity, nasal oedema, sneezing, upper airway obstruction. Revatio dosage: . During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), TRACLEER (View Tracleer Review and Tracleer Label ).

6805629-9 | Diarrhoea, Epistaxis
on Mar 18, 2008 Female patient from UNITED STATES , weighting 123.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: diarrhoea, epistaxis. Revatio dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LASIX (View Lasix Review and Lasix Label ), POTASSIUM (View Potassium Review and Potassium Label ), LIPITOR (View Lipitor Review and Lipitor Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), ZETIA (View Zetia Review and Zetia Label ), IRON (View Iron Review and Iron Label ).

6805532-4 | Deafness
Patient was taking Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: deafness on Dec 11, 2007 from UNITED STATES Additional patient health information: Female patient , 40 years of age, was diagnosed with pulmonary arterial hypertension and. Revatio dosage: . During the same period patient was treated with MACRODANTIN (View Macrodantin Review and Macrodantin Label ), LASIX (View Lasix Review and Lasix Label ), SINGULAIR ^DIECKMANN^ (View Singulair ^dieckmann^ Review and Singulair ^dieckmann^ Label ), CARDIZEM CD (View Cardizem Cd Review and Cardizem Cd Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

6805377-5 | Amenorrhoea
Adverse event was reported on Oct 25, 2007 by a Female patient taking Revatio (View Usage) (Dosage: ) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , weighting 300.0 lb, Patient had the following side effects: amenorrhoea.

6805346-5 | Burn Oesophageal, Dizziness, Dyspepsia, Dyspnoea, Flushing, Headache, Pyrexia, Vision Blurred
on Oct 22, 2007 Female patient from UNITED STATES , weighting 115.1 lb, was diagnosed with cardiac disorder and was treated with Revatio (View Usage). After Revatio was administered, patient had the following side effects: burn oesophageal, dizziness (What is dizziness?), dyspepsia, dyspnoea, flushing, headache (What is headache?), pyrexia, vision blurred. Revatio dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), LASIX (View Lasix Review and Lasix Label ), POTASSIUM (View Potassium Review and Potassium Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

6803424-8 | Monoplegia
on Jun 17, 2010 Female patient from UNITED STATES , weighting 99.98 lb, was diagnosed with emphysema, dyspnoea and was treated with Revatio (View Usage). Patient experienced the following unwanted or unexpected effects: monoplegia. Revatio dosage: 20 Mg, 2x/day. During the same period patient was treated with TRACLEER (Unk) (View Tracleer Review and Tracleer Label ), SPIRIVA (Unk) (View Spiriva Review and Spiriva Label ), ADVAIR DISKUS 100/50 (Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (Unk) (View Albuterol Review and Albuterol Label ).

6802214-X | Abdominal Pain, Fatigue, Gastrooesophageal Reflux Disease, Incorrect Dose Administered, Therapeutic Response Decreased, Vulvovaginal Discomfort
Patient was taking Revatio (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), fatigue, gastrooesophageal reflux disease, incorrect dose administered, therapeutic response decreased, vulvovaginal discomfort on Mar 31, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 190.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Revatio dosage: 20 Mg, 3x/day. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), VICODIN (View Vicodin Review and Vicodin Label ).